MedTrace Logo

Hospital Based Continuous Patient Monitoring System

NCT06739447 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-05-06

No results posted yet for this study

Summary

In Ghana, and many other low and middle income countries in Africa, manual vital signs monitoring is the prevalent mode of vital signs monitoring because continuous bedside monitors are non-functional. This lack of continuous vital signs monitoring may result in missed opportunities to catch physiologic deterioration.

The investigators propose to develop a dashboard that is based on the Garmin Venu 3, a consumer wearable device that reliably measures heart rate, SPO2, and respiratory rate, as an alternative to bedside monitors in hospitals in Ghana.

Conditions

  • Trauma
  • Appendectomy
  • Pediatric ALL
  • Vital Signs Monitoring

Interventions

OTHER

Consumer Wearable Device Vital Sign Measurement

Consumer Wearable Devices such as the Fitbit, are durable devices that can provide vital sign data.

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • University of Ghana

    collaborator OTHER

  • Loyola University

    collaborator OTHER

  • University of Alabama at Birmingham

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2029-11-30
Completion
2030-01-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06739447 on ClinicalTrials.gov